The role of endomyocardial biopsy in the management of cardiovascular disease: a Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
Open accessThe DOI matches its Crossref record.
Abstract
May we draw your attention to the ESC/AHA/ACC scientific statement published in the December issue of the European Heart Journal.1 Scenario 10 discusses the indication for endomyocardial biopsy in patients with suspected myocardial siderosis (due to hereditary or acquired haemochromatosis). This states that ‘cardiac involvement in haemochromatosis usually can be diagnosed on the basis of history, clinical examination, and echocardiography or cardiac magnetic resonance (CMR) demonstrating dilated cardiomyopathy in the setting of laboratory abnormalities such as elevated serum iron and haemochromatosis gene mutation’. On the contrary, cardiac siderosis often presents late, and ventricular dimensions may be normal until the late stages of disease.2 In addition, conventional markers for iron overload such as serum ferritin and liver iron have been shown to bear no relation to myocardial iron deposition in the commonest form of acquired myocardial siderosis, beta-thalassaemia major.3 However, if access to CMR is indeed available, a robust, simple and quick measurement of myocardial T2* (acquired during a single 10-s breath hold scan on modern scanners) can provide an accurate assessment of myocardial iron load.4 Furthermore, this measurement has been cross-validated across scanners from each of the major manufacturers, making this technique readily accessible.5 We would, therefore, propose that myocardial biopsy for assessment of iron overload should only be performed if access to CMR and measurement of T2* is not available or if aetiologies other than iron overload are being assessed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872
Heymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J.-L., Cohen-Tervaert, J. W., Drexler, H., Filippatos, G., Felix, S. B., Gullestad, L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 323
Seferović, P. M., Tsutsui, H., McNamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2190 · Cited by 219
Baritussio, A., Schiavo, A., Basso, C., Giordani, A. S., Cheng, C., Pontara, E., Cattini, M. G., Bison, E., Gallo, N., De Gaspari, M., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2496 · Cited by 90
The Clinicopathological Profile of Eosinophilic Myocarditis
Sheikh, H., Siddiqui, M., Uddin, S. M. M., Haq, A., & Yaqoob, U. (2018) · Cureus · doi:10.7759/cureus.3677 · Cited by 36
Metadata
- Authors
- Anderson, L., & Pennell, D.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06-13
- Volume
- 29
- Issue
- 13
- Pages
- 1696-1696
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2039460756
- Cited by
- 108
- References
- 0
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of endomyocardial biopsy in the management of cardiovascular disease: a Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. https://app.cochat.ai/papers/10.1093/eurheartj/ehn189
- The paper
- Anderson, L., & Pennell, D. (2008). The role of endomyocardial biopsy in the management of cardiovascular disease: a Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. European Heart Journal. https://doi.org/10.1093/eurheartj/ehn189
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.